Embecta Corp.

NASDAQ

Market Cap.

683.4M

Avg. Volume

470.56K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Embecta Corp.

Embecta Corp. News

Embecta Corp. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareDrug Manufacturers - Specialty & Generic
embecta.com

About Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

Embecta Corp. Earnings & Revenue

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Embecta Corp. Financials

Table Compare

Compare EMBC metrics with:

   

Earnings & Growth

EMBC

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

EMBC

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

EMBC

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

EMBC

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Embecta Corp. Income

Embecta Corp. Balance Sheet

Embecta Corp. Cash Flow

Embecta Corp. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityStrong Sell
Return on AssetsStrong Buy
Debt/Equity RatioStrong Sell
Price/Earnings RatioNeutral
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Embecta Corp. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.6000

Payment DateDividendFrequency
2025-12-180.15Quarterly
2025-09-150.15Quarterly
2025-06-130.15Quarterly
2025-03-140.15Quarterly
2024-12-180.15Quarterly

Historical Market Cap

Shares Outstanding

Embecta Corp. Executives

NameRole
Mr. Devdatt Kurdikar Ph.D.President, Chief Executive Officer & Director
Mr. Jacob P. ElguiczeSenior Vice President & Chief Financial Officer
Mr. Shaun CurtisSenior Vice President of Global Manufacturing & Supply Chain
Mr. Jeffrey Z. MannSenior Vice President, General Counsel, Head of Business Development & Corporate Secretary
Ms. Jean M. CasnerSenior Vice President & Chief Human Resources Officer
NameRoleGenderDate of BirthPay
Mr. Devdatt Kurdikar Ph.D.President, Chief Executive Officer & DirectorMale19692.34M
Mr. Jacob P. ElguiczeSenior Vice President & Chief Financial OfficerMale19731.12M
Mr. Shaun CurtisSenior Vice President of Global Manufacturing & Supply ChainMale19701.03M
Mr. Jeffrey Z. MannSenior Vice President, General Counsel, Head of Business Development & Corporate SecretaryMale1972993.2K
Ms. Jean M. CasnerSenior Vice President & Chief Human Resources OfficerFemale1958811.22K

Embecta Corp. Insider Trades

Date26 Nov
NameMann Jeffrey Z
RoleOfficer
TransactionDisposed
Type
Shares0
Date26 Nov
NameElguicze Jacob
RoleOfficer
TransactionDisposed
Type
Shares0
Date26 Nov
NameRoth Anthony M.
RoleChief Accounting Officer
TransactionAcquired
TypeA-Award
Shares32817
Date26 Nov
NameRoth Anthony M.
RoleChief Accounting Officer
TransactionDisposed
TypeF-InKind
Shares1881
Date26 Nov
NameCasner Jean
RoleChief Human Resources Officer
TransactionAcquired
TypeA-Award
Shares38783
DateNameRoleTransactionTypeShares
26 NovMann Jeffrey ZOfficerDisposed0
26 NovElguicze JacobOfficerDisposed0
26 NovRoth Anthony M.Chief Accounting OfficerAcquiredA-Award32817
26 NovRoth Anthony M.Chief Accounting OfficerDisposedF-InKind1881
26 NovCasner JeanChief Human Resources OfficerAcquiredA-Award38783

Discover More

Streamlined Academy

Embecta Corp.

NASDAQ

Market Cap.

683.4M

Avg. Volume

470.56K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Embecta Corp. News

Embecta Corp. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Embecta Corp. Earnings & Revenue

Embecta Corp. Income

Embecta Corp. Balance Sheet

Embecta Corp. Cash Flow

Embecta Corp. Financials Over Time

Embecta Corp. Executives

NameRole
Mr. Devdatt Kurdikar Ph.D.President, Chief Executive Officer & Director
Mr. Jacob P. ElguiczeSenior Vice President & Chief Financial Officer
Mr. Shaun CurtisSenior Vice President of Global Manufacturing & Supply Chain
Mr. Jeffrey Z. MannSenior Vice President, General Counsel, Head of Business Development & Corporate Secretary
Ms. Jean M. CasnerSenior Vice President & Chief Human Resources Officer
NameRoleGenderDate of BirthPay
Mr. Devdatt Kurdikar Ph.D.President, Chief Executive Officer & DirectorMale19692.34M
Mr. Jacob P. ElguiczeSenior Vice President & Chief Financial OfficerMale19731.12M
Mr. Shaun CurtisSenior Vice President of Global Manufacturing & Supply ChainMale19701.03M
Mr. Jeffrey Z. MannSenior Vice President, General Counsel, Head of Business Development & Corporate SecretaryMale1972993.2K
Ms. Jean M. CasnerSenior Vice President & Chief Human Resources OfficerFemale1958811.22K

Embecta Corp. Insider Trades

Date26 Nov
NameMann Jeffrey Z
RoleOfficer
TransactionDisposed
Type
Shares0
Date26 Nov
NameElguicze Jacob
RoleOfficer
TransactionDisposed
Type
Shares0
Date26 Nov
NameRoth Anthony M.
RoleChief Accounting Officer
TransactionAcquired
TypeA-Award
Shares32817
Date26 Nov
NameRoth Anthony M.
RoleChief Accounting Officer
TransactionDisposed
TypeF-InKind
Shares1881
Date26 Nov
NameCasner Jean
RoleChief Human Resources Officer
TransactionAcquired
TypeA-Award
Shares38783
DateNameRoleTransactionTypeShares
26 NovMann Jeffrey ZOfficerDisposed0
26 NovElguicze JacobOfficerDisposed0
26 NovRoth Anthony M.Chief Accounting OfficerAcquiredA-Award32817
26 NovRoth Anthony M.Chief Accounting OfficerDisposedF-InKind1881
26 NovCasner JeanChief Human Resources OfficerAcquiredA-Award38783

Streamlined Academy

Website screenshot
HealthcareDrug Manufacturers - Specialty & Generic
embecta.com

About Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Embecta Corp.

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Embecta Corp. Financials

Table Compare

Compare EMBC metrics with:

   

Earnings & Growth

EMBC

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

EMBC

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

EMBC

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

EMBC

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Embecta Corp. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

0.6000

Payment DateDividendFrequency
2025-12-180.15Quarterly
2025-09-150.15Quarterly
2025-06-130.15Quarterly
2025-03-140.15Quarterly
2024-12-180.15Quarterly

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityStrong Sell
Return on AssetsStrong Buy
Debt/Equity RatioStrong Sell
Price/Earnings RatioNeutral
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

The Secret to Analyzing Winning Stocks (Step-by-Step Examples Inside)